Watkins Tim — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Watkins Tim has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $279K.

Profile

Tim Watkins is the Chief Medical Officer and Head of Development at Contineum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on NI&I indications. In this role, he leads the company’s clinical development strategy and execution, including programs such as PIPE-791 and PIPE-307. The SEC filing dated 2026-01-30 lists him as an insider with no reported purchases or sales.

Board memberships

• Contineum Therapeutics, Inc.

Awards & honors

• Leads clinical development strategy and execution for Contineum's pipeline
• Oversees medical affairs as Chief Medical Officer

Recent Transactions

Companies — Last 90 Days

• Contineum Therapeutics, Inc. (CTNM) — 1 filings, last 2026-07-01

Frequently Asked Questions

Who is Watkins Tim?

Tim Watkins is the Chief Medical Officer and Head of Development at Contineum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on NI&I indications. In this role, he leads the company’s clinical development strategy and execution, including programs such as PIPE-791 and PIPE-307. The SEC filing dated 2026-01-30 lists him as an insider with no reported purch…

How many SEC Form 4 filings has Watkins Tim submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Watkins Tim been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 4 open-market sales ($279K) across all tracked filings.

Where can I see all of Watkins Tim's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week